by MiraVista Admin | Jan 17, 2018 | Announcement Archive, Events
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA...
by MiraVista Admin | Sep 25, 2017 | Announcement Archive, Events
MiraVista Diagnostics is participating in 2017 ID Week in San Diego on October 4-8, 2017. Representatives from the company’s clinical laboratory team will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal...
by MiraVista Admin | Aug 14, 2017 | Announcement Archive, Events
August 14–18, 2017, is the first Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista...
by MiraVista Admin | Aug 7, 2017 | Announcement Archive, Events
MiraVista Diagnostics is participating in the 2017 Coccidioidomycosis Study Group Symposium on August 11-13 at the Stanford University Medical School. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of...
by MiraVista Admin | May 30, 2017 | Events
MiraVista Diagnostics is exhibiting at ASM Microbe 2017 in New Orleans on June 1-5. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections.
by MiraVista Admin | Apr 24, 2017 | Events
MiraVista Diagnostics is participating in the 2017 Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference in Toronto on May 3-6, 2017. Representatives from the company’s clinical laboratory will be available to discuss...